Einfluss der Chemotherapie auf die Lebensqualität bei Patienten mit ...

Weitere Magazine

Empfehlungen

Info

LQ-Studie, Version 1.0, 5. Jänner 2007 Seite 126 Literatur1. Aaronson N, Ahmedzai S, Bergman B et al. : The European Organization forResearch and Treatment of Cancer QLQ-C30: A Quality-of-life instrument for use ininternational trials in oncology. Cancer Inst, Vol. 85, 365-376, 1993.2. Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Quality of life in patients withcolorectal cancer 1 year after diagnosis compared with the general population: apopulation-based study. J Clin Oncol. 2004 Dec 1;22(23):4829-36. Erratum in: J ClinOncol. 2005 Jan 1;23(1):248.3. Becker N, Muscat JE, Wynder EL. Cancer mortality in the United States andGermany. J Cancer Res Clin Oncol 2001; 127: 293-300.4. Borner MM, Bernhard J, Dietrich D, Popescu R, Wernli M, Saletti P, Rauch D,Herrmann R, Koeberle D, Honegger H, Brauchli P, Lanz D, Roth AD; Swiss Groupfor Clinical Cancer Research (SAKK), Berne, Switzerland A randomized phase II trialof capecitabine and two different schedules of irinotecan in first-line treatment ofmetastatic colorectal cancer: efficacy, quality-of-life and toxicity. Ann Oncol. 2005Feb;16(2):282-8.5. Buxton J, White M, Osoba D. Patients` Experiences using a computerized programwith a touch-sensitive video monitor for the assessment of health-related quality oflife. Quality of Life Research, Vol. 7, 513-519, 1998.6. Camilleri-Brennan J, Steele RJ. Prospective analysis of Quality of Life and survivalfollowing mesorectal excision for rectal cancer. Br J Surg 2001; 88: 1617-1622.7. Casali P, Licitra L, Costantini M (1997). Quality of life assessment and clinicaldecision making. Ann-Oncol, 8(12), 1207-11.8. Chang CH, Cella D, Masters GA, Laliberte N, O`Brien P, Peterman A, Shevrin D.(2002). Real-Time clinical application of quality of life assessment in advanced lungcancer. Clinical Lung Cancer.9. Chatwin NA, Ribordy M, Givel JC. Clinical outcomes and quality of life after lowanterior resection for rectal cancer. Eur J Surg. 2002; 168: 297-30110. Chau I, Norman AR, Cunningham D, Iveson T, Hill M, Hickish T, Lofts F, Jodrell D,Webb A, Tait D, Ross PJ, Shellito P, Oates JR. Longitudinal quality of life and qualityadjusted survival in a randomised controlled trial comparing six months of bolusfluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil asadjuvant chemotherapy for colorectal cancer. Eur J Cancer. 2005 Jul;41(11):1551-9.11. Coates A, Porzsold F, Osoba D. Quality of life in oncology practice: prognostic valueof EORTC QLQ-C-30 scores in patients with advanced malignancies. Eur J Cancer1997; 33: 1025.1030.12. Davidson-Homewood J, Norman A, Küchler T, Cunningham D, Watson M.Development of a disease specific questionnaire to supplement a generic tool forQoL in colorectal cancer. Psychooncology 2003; 12: 675-685.13. Davis K, Cella D. Assessing Quality of life in Oncology Clinical Practice: A Review ofBarriers and Critical Success Factors. JCOM, Vol. 9, Nr.6, 327-332, 2002.14. de Kort SJ, Willemse PH, Habraken JM, de Haes HC, Willems DL, Richel DJ Qualityof life versus prolongation of life in patients treated with chemotherapy in advancedcolorectal cancer: A review of randomized controlled clinical trials. Eur J Cancer.2006 Feb 1315. Detmar SB, Aaronson NK. Quality of life assessment in daily clinical oncologypractice: a feasibility study. Eur J Cancer, Vol. 34, 1181-1186, 1998.16. Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Schoffski P, Schmoll H,Van Cutsem E, Kohne CH. Does a patient's self-reported health-related quality of life
LQ-Studie, Version 1.0, 5. Jänner 2007 Seite 13predict survival beyond key biomedical data in advanced colorectal cancer? Eur JCancer. 2006 Jan;42(1):42-9. Epub 2005 Nov 1817. Fayers P, Bottomley A; EORTC Quality of Life Group; Quality of Life Unit. Quality oflife research within the EORTC-the EORTC QLQ-C30. European Organisation forResearch and Treatment of Cancer.Eur J Cancer. 2002 Mar;38 Suppl 4:S125-3318. Fischer F, Mirow L, Gondeck C, Schwandner O, Bruch HP, Farke S. Influence ofadjuvant radio-chemotherapy for rectal cancer on quality of life Z Gastroenterol.2005 Nov;43(11):1213-8.19. Glare P, Virik K, Jones M, et al. A systematic review of physicians’ survivalpredictions in terminally ill cancer patients. BMJ 2003;327:195.20. Higginson IJ, Carr AJ. Measuring quality of life: Using quality of life measures in theclinical setting. BMJ, Vol. 322/7297, 1297-1300, 2001.21. Holzner B, Kemmler G, Moschen R, Schweigkofler H, Kopp M, Dünser M, Ramoni A,Margreiter R, Fleischhacker WW, Sperner-Unterweger B (2001): Quality of Life inBreast Cancer Patients – not enough attention to long-term survivors.Psychosomatics; 42(2): 117-123.22. Holzner B, Kopp M, Kemmler G, DeCol Ch, Greil R, Zeimet AG, Raderer M, HejnaM, Zöchbauer S, Krajnik G, Huber H, Sperner-Unterweger B (2002): The impact ofhemoglobin levels on fatigue and quality of life in cancer patients. Annals ofOncology, 13, 965-973.23. Holzner B, Kemmler G, Cella D, De Paoli Ch, Meraner V, Kopp M, Greil R,Fleischhacker WW Sperner-Unterweger B. Normative Data for FACT-G and its usefor the interpretation of Quality of Life Scores in Cancer Survivors. Acta Oncol.2004;43(2):153-6024. Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A. TheEORTC core quality of life questionnaire (QLQ-C30): validity and reliability whenanalysed with patients treated with palliative radiotherapy. Eur J Cancer 1995; 31A:2260-226325. Kabashima A, Sakaguchi Y, Okita K, Yamamura S, Ojima Y, Nishizaki T, Tashiro H,Matsuzaka T. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced orrecurrent colorectal cancer]Gan To Kagaku Ryoho. 2005 Nov;32(12):1935-826. Köhne CH, Cunningham D, Di Costanzo F, et al. Clinical determinantes of survival inpatients with 5-fluorouracil-based treatment for metastatic colorectal cancer: resultsof a multivariate analysis of 3825 patients. Ann Oncol 2002;13:308-17.27. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, FleischhackerWW, Sperner-Unterweger B (2000): EORTC QLQ-C30 and FACT-G for themeasurement of qol in bone marrow transplant recipients: a comparison; EuropeanJournal of Haematology 65(2): 97-103.28. Osoba D, Aaronson N, Zee B, Sprangers M, te VA. Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples ofpatients with cancer. The Study Group on Quality of Life of the EORTC and theSymptom Control and Quality of Life Committees of the NCI of Canada ClinicalTrials Group. Qual Life Res 1997; 6: 103-10829. Osoba D, Hsu MA, Copley-Merriman C, Coombs J, Johnson FR, Hauber B,Manjunath R, Pyles A. Stated preferences of patients with cancer for health-relatedquality-of-life (HRQOL) domains during treatment. Qual Life Res. 2006Mar;15(2):273-8330. Schmidt CE, Bestmann B, Kuchler T, Longo WE, Kremer B. Ten-year historic cohortof quality of life and sexuality in patients with rectal cancer. Dis Colon Rectum. 2005Mar;48(3):483-92.
Seite 1: LQ-Studie, Version 1.0, 5. Jänner
Seite 4 und 5: LQ-Studie, Version 1.0, 5. Jänner
Seite 11: LQ-Studie, Version 1.0, 5. Jänner

Einfluss der Chemotherapie auf die Lebensqualität bei Patienten mit ...

Erfolgreiche ePaper selbst erstellen

Template löschen?

Als Template speichern?